Z-1484-2026 Class II Ongoing
FDA device recall Z-1484-2026 was initiated by Siemens Healthcare Diagnostics, Inc. on Jan 20, 2026 and is designated Class II. Reason for recall: Falsely depressed UAlb patient results may occur. Affected samples with any urine albumin concentration above the UAlb measuring interval >40.0 mg/dL may report values between 6.2 mg/dL and 40.0… The recall status is ongoing. Affected quantity: 4,885 units.
Recall details
- Product Type
- Devices
- Report Date
- Mar 11, 2026
- Initiation Date
- Jan 20, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 4,885 units
Product description
Reason for recall
Distribution pattern
Worldwide distribution - US Nationwide and the countries of Australia, Austria, Belgium, Brazil, Canada, Chile, Curacao,¿St¿Eus, Czech¿Republic, Denmark, Finland, France, Germany, Greece, Hong Kong, Ireland, Israel, Italy, Korea, Latvia, Malaysia, Netherlands, New Zealand, Norway, Portugal, Romania, Singapore, Slovakia, South Africa, Spain, Sweden, Switzerland, United¿Kingdom.
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-1484-2026
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026